- Home
- LNTH vs ADC Comparison
LNTH vs ADC Comparison
Compare LNTH & ADC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- ADC
- Stock Information
- Founded
- LNTH 1956
- ADC 1971
- Country
- LNTH United States
- ADC United States
- Employees
- LNTH N/A
- ADC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ADC Real Estate Investment Trusts
- Sector
- LNTH Health Care
- ADC Real Estate
- Exchange
- LNTH Nasdaq
- ADC Nasdaq
- Market Cap
- LNTH 7.5B
- ADC 8.5B
- IPO Year
- LNTH 2015
- ADC 1994
- Fundamental
- Price
- LNTH $81.74
- ADC $75.15
- Analyst Decision
- LNTH Strong Buy
- ADC Buy
- Analyst Count
- LNTH 5
- ADC 14
- Target Price
- LNTH $133.80
- ADC $80.73
- AVG Volume (30 Days)
- LNTH 1.2M
- ADC 1.5M
- Earning Date
- LNTH 05-07-2025
- ADC 04-22-2025
- Dividend Yield
- LNTH N/A
- ADC 4.02%
- EPS Growth
- LNTH N/A
- ADC 4.57
- EPS
- LNTH 3.53
- ADC 1.77
- Revenue
- LNTH $1,536,699,000.00
- ADC $636,802,000.00
- Revenue This Year
- LNTH $5.81
- ADC $11.31
- Revenue Next Year
- LNTH $12.26
- ADC $10.71
- P/E Ratio
- LNTH $23.18
- ADC $42.49
- Revenue Growth
- LNTH 12.53
- ADC 13.65
- 52 Week Low
- LNTH $74.34
- ADC $58.38
- 52 Week High
- LNTH $126.89
- ADC $79.65
- Technical
- Relative Strength Index (RSI)
- LNTH 29.92
- ADC 44.63
- Support Level
- LNTH $78.92
- ADC $75.71
- Resistance Level
- LNTH $108.91
- ADC $77.29
- Average True Range (ATR)
- LNTH 3.82
- ADC 1.43
- MACD
- LNTH -2.81
- ADC -0.28
- Stochastic Oscillator
- LNTH 9.40
- ADC 12.28
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About ADC Agree Realty Corporation
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.